No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Talazoparib plus enzalutamide improves progression-free survival in metastatic prostate cancer

byBryan Sun

August 18, 2023

in StudyGraphics

Reading Time: 1 min read

Click to read the study in The Lancet

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

Stockholm3 outperforms PSA for detecting significant prostate cancer

Pfizer’s Talzenna combo significantly delays prostate cancer progression

Tags: prostate cancer talazoparib

Delivery at 39 weeks is recommended for pregnancies conceived via infertility treatments and assisted reproductive technology

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

July 22, 2026

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Oncology

Stockholm3 outperforms PSA for detecting significant prostate cancer

June 22, 2026

Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Decline in adolescent sleep duration over past 20 years

Long sleep duration may be associated with carotid plaque burden

Age and number of islet autoantibodies associated with diabetes risk

Nemolizumab Therapy for Moderate-to-Severe Prurigo Nodularis

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE)

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result